<DOC>
	<DOCNO>NCT00685191</DOCNO>
	<brief_summary>The study purpose investigate plasma HIV-1 RNA dynamic subject initiate raltegravir-based salvage therapy quantify corresponding change level cellular HIV-1 DNA .</brief_summary>
	<brief_title>HIV-1 Viral Dynamics Subjects Initiating Raltegravir Therapy Spain</brief_title>
	<detailed_description>First- second-phase decay rate plasma HIV-1 RNA change intracellular level HIV-1 proviral DNA LTR circle measure subject start salvage antiretroviral therapy include raltegravir Spain .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Raltegravir Potassium</mesh_term>
	<criteria>Patients limit treatment option due extensive antiretroviral drug resistance drug intolerance . Subjects initiate raltegravir plus another fully active antiretroviral drug . Pregnancy , fertile woman willing pregnant . Active substance abuse major psychiatric disease .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
	<keyword>Raltegravir</keyword>
	<keyword>HIV</keyword>
	<keyword>dynamic</keyword>
	<keyword>viral load</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>